LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Reset all filters
01 1LGM Pharma
02 1HRV Global Life Sciences
03 1Actavis Inc
04 1Acura Labs
05 1Anhui HaiKang Pharmaceutical
06 1Anwita Drugs
07 1Asymchem Laboratories
08 1Aurobindo Pharma Limited
09 1Biocon
10 1Boehringer Ingelheim GmbH
11 1Chromo Laboratories
12 1Darou Pakhsh Pharma Chem
13 1Hy-Gro Chemicals
14 1Jubilant Generics
15 1Jubilant Pharmova
16 1Macleods Pharmaceuticals Limited
17 1Murli Krishna Pharma
18 1Saintsun Pharma
19 1Shouyuan Chemical
20 1Smilax Laboratories Limited
21 1Stason Pharmaceuticals, Inc.
22 2Sun Pharmaceutical Industries Limited
23 1Synergene Active Ingredients Pvt Ltd
24 1TIANJIN GENCOM PHARMACEUTICAL CO LTD
25 1Torrent Pharmaceuticals Limited
26 2USV Private Limited
27 1Zhejiang Hisoar Pharmaceutical
Reset all filters
01 6China
02 1Germany
03 18India
04 1Iran
05 1Ireland
06 2U.S.A
Reset all filters
01 10Active
02 2Inactive
03 17Blank
01 11Valid
02 18Blank
Reset all filters
01 1221MF10144
02 1231MF10044
03 1306MF10117
04 26Blank
Reset all filters
01 1WC-0011nA2
02 1WC-0012
03 1WC-0023
04 1WC-0079
05 1WC-0109A
06 1WC-0168
07 1WC-0176
08 1WC-0317
09 21Blank
Reset all filters
01 120210615-209-J-1027
02 120211028-209-J-1132
03 27Blank
Reset all filters
01 152562-500
02 162147-0013
03 162147-0055
04 165372-1155
05 165727-010
06 165862-532
07 23Blank
01 29Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26396
Submission : 2012-09-10
Status : Active
Type : II
Certificate Number : R1-CEP 2012-087 - Rev 00
Issue Date : 2018-09-27
Type : Chemical
Substance Number : 2135
Status : Valid
Date of Issue : 2022-02-02
Valid Till : 2024-06-07
Written Confirmation Number : WC-0317
Address of the Firm :
NDC Package Code : 52562-500
Start Marketing Date : 2012-08-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25663
Submission : 2012-01-03
Status : Active
Type : II
Certificate Number : R1-CEP 2011-308 - Rev 00
Issue Date : 2017-08-18
Type : Chemical
Substance Number : 2135
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18329
Submission : 2005-05-09
Status : Active
Type : II
Certificate Number : R1-CEP 2009-239 - Rev 02
Issue Date : 2019-02-22
Type : Chemical
Substance Number : 2135
Status : Valid
Date of Issue : 2022-06-27
Valid Till : 2025-06-02
Written Confirmation Number : WC-0012
Address of the Firm :
NDC Package Code : 62147-0055
Start Marketing Date : 2009-12-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19620
Submission : 2006-07-24
Status : Active
Type : II
Certificate Number : R1-CEP 2006-123 - Rev 00
Issue Date : 2012-09-25
Type : Chemical
Substance Number : 2135
Status : Valid
Registration Number : 221MF10144
Registrant's Address : Binger Strasse 173,55216 Ingelheim am Rhein
Initial Date of Registration : 2009-07-09
Latest Date of Registration :
Registrant Name : Novo Nordisk Pharmaceuticals Co., Ltd.
Registration Date : 2021-10-28
Registration Number : 20211028-209-J-1132
Manufacturer Name : Boehringer Ingelheim Pharma GmbH & Co KG
Manufacturer Address : Binger Strasse 173, D-55216 Ingelheim am Rhein, Germany
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-07-07
Pay. Date : 2013-09-23
DMF Number : 22234
Submission : 2008-11-18
Status : Active
Type : II
Certificate Number : R1-CEP 2009-375 - Rev 01
Issue Date : 2016-01-21
Type : Chemical
Substance Number : 2135
Status : Valid
Date of Issue : 2019-11-28
Valid Till : 2022-07-02
Written Confirmation Number : WC-0079
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17825
Submission : 2004-11-10
Status : Active
Type : II
Certificate Number : R1-CEP 2006-069 - Rev 02
Issue Date : 2015-05-26
Type : Chemical
Substance Number : 2135
Status : Valid
Date of Issue : 2022-08-08
Valid Till : 2025-07-14
Written Confirmation Number : WC-0168
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29922
Submission : 2015-10-08
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19010
Submission : 2005-12-07
Status : Inactive
Type : II
Date of Issue : 2022-06-08
Valid Till : 2025-06-02
Written Confirmation Number : WC-0011nA2
Address of the Firm :
12
PharmaCompass offers a list of Repaglinide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Repaglinide manufacturer or Repaglinide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Repaglinide manufacturer or Repaglinide supplier.
PharmaCompass also assists you with knowing the Repaglinide API Price utilized in the formulation of products. Repaglinide API Price is not always fixed or binding as the Repaglinide Price is obtained through a variety of data sources. The Repaglinide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Repaglinide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Repaglinide, including repackagers and relabelers. The FDA regulates Repaglinide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Repaglinide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Repaglinide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Repaglinide supplier is an individual or a company that provides Repaglinide active pharmaceutical ingredient (API) or Repaglinide finished formulations upon request. The Repaglinide suppliers may include Repaglinide API manufacturers, exporters, distributors and traders.
click here to find a list of Repaglinide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 27 companies offering Repaglinide
Get in contact with the supplier of your choice: